SCLX FY 2022 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

FY 2022 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$38M+21.4% YoY

Gross Profit

$27M71.6% margin

Operating Income

-$51M-133.1% margin

Net Income

-$23M-61.4% margin

EPS (Diluted)

$-6.09

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$23M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$87M

Total Liabilities

$50M

Stockholders' Equity

$36M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$31M	+21.4%
Gross Profit	$27M	$28M	-1.6%
Operating Income	-$51M	-$36M	-41.3%
Net Income	-$23M	-$88M	+73.6%